1. Home
  2. APVO vs ITP Comparison

APVO vs ITP Comparison

Compare APVO & ITP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • ITP
  • Stock Information
  • Founded
  • APVO 2016
  • ITP 1996
  • Country
  • APVO United States
  • ITP China
  • Employees
  • APVO N/A
  • ITP N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • ITP Paper
  • Sector
  • APVO Health Care
  • ITP Basic Materials
  • Exchange
  • APVO Nasdaq
  • ITP Nasdaq
  • Market Cap
  • APVO 4.1M
  • ITP 3.5M
  • IPO Year
  • APVO N/A
  • ITP N/A
  • Fundamental
  • Price
  • APVO $3.23
  • ITP $0.18
  • Analyst Decision
  • APVO Strong Buy
  • ITP
  • Analyst Count
  • APVO 1
  • ITP 0
  • Target Price
  • APVO $5,920.00
  • ITP N/A
  • AVG Volume (30 Days)
  • APVO 6.7M
  • ITP 1.2M
  • Earning Date
  • APVO 08-07-2025
  • ITP 08-11-2025
  • Dividend Yield
  • APVO N/A
  • ITP N/A
  • EPS Growth
  • APVO N/A
  • ITP N/A
  • EPS
  • APVO N/A
  • ITP N/A
  • Revenue
  • APVO N/A
  • ITP $79,871,368.00
  • Revenue This Year
  • APVO N/A
  • ITP N/A
  • Revenue Next Year
  • APVO N/A
  • ITP N/A
  • P/E Ratio
  • APVO N/A
  • ITP N/A
  • Revenue Growth
  • APVO N/A
  • ITP 8.49
  • 52 Week Low
  • APVO $2.81
  • ITP $0.15
  • 52 Week High
  • APVO $485.37
  • ITP $1.07
  • Technical
  • Relative Strength Index (RSI)
  • APVO 34.28
  • ITP 45.22
  • Support Level
  • APVO $2.81
  • ITP $0.18
  • Resistance Level
  • APVO $13.11
  • ITP $0.22
  • Average True Range (ATR)
  • APVO 1.10
  • ITP 0.02
  • MACD
  • APVO 0.30
  • ITP 0.00
  • Stochastic Oscillator
  • APVO 4.08
  • ITP 20.00

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About ITP IT Tech Packaging Inc.

IT Tech Packaging Inc is a holding company engaged in the business of paper manufacturing in China. The company operates as a producer and distributor of paper products. It is involved in the production and distribution of three categories of paper products: packing paper (corrugating medium paper), offset printing paper, and tissue paper products. It also produces digital photo paper. Its business is structured into three segments: Dongfang Paper and Tengsheng Paper, which produce offset printing paper, corrugating medium paper, and tissue paper, and Baoding Shengde, which produces face masks and digital photo paper.

Share on Social Networks: